Friday, July 13, 2018

KemPharm announces promising trial results for ADHD prodrug - Business Record


KemPharm announces promising trial results for ADHD prodrug
Business Record
Corridor Business Journal:Coralville-based KemPharm announced this week that its prodrug treatment for attention deficit/hyperactivity disorder (ADHD) in patients between the ages of 6-12, called KP415, has met primary and secondary efficacy endpoints.

No comments:

Post a Comment